HIV/AIDS News and Research RSS Feed - HIV/AIDS News and Research Twitter

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

This condition progressively reduces the effectiveness of the immune system and leaves individuals susceptible to opportunistic infections and tumors. HIV is transmitted through direct contact of a mucous membrane or the bloodstream with a bodily fluid containing HIV, such as blood, semen, vaginal fluid, preseminal fluid, and breast milk.
Findings highlight importance of IL-21 in the development of antiviral vaccines

Findings highlight importance of IL-21 in the development of antiviral vaccines

Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections. [More]
Novel multiplex immunoassay approach to capture HIV antibodies

Novel multiplex immunoassay approach to capture HIV antibodies

Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies and can measure even small amounts of multiple antibodies at one time. [More]

New campaign aims to increase awareness of HIPAA rights, benefits among HIV-positive Black MSM

The U.S. Department of Health and Human Services, Office for Civil Rights is proud to launch the Information Is Powerful Medicine campaign. [More]
Immune system attacks beneficial bacteria in several chronic human diseases

Immune system attacks beneficial bacteria in several chronic human diseases

The human gut is loaded with commensal bacteria - "good" microbes that, among other functions, help the body digest food. The gastrointestinal tract contains literally trillions of such cells, and yet the immune system seemingly turns a blind eye. However, in several chronic human diseases such as inflammatory bowel disease, HIV/AIDS, cancer, cardiovascular disease, and diabetes, the immune system attacks these normally beneficial bacteria, resulting in chronic inflammation and contributing to disease progression. [More]
Sorrento Therapeutics' anti-MRSA program gets NIAID support

Sorrento Therapeutics' anti-MRSA program gets NIAID support

Sorrento Therapeutics, Inc. announced today that its Fast-Track Advanced Technology Small Business Technology Transfer Research grant (#1R42AI098182-02) from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, supporting the development of novel human antibody therapeutics to combat Staphylococcus aureus (S. aureus or Staph) infections, including methicillin-resistant S. aureus, was renewed for the second year of a two year Phase I grant award. [More]
FDA approves Mylan's ANDA for Fenofibrate Tablets

FDA approves Mylan's ANDA for Fenofibrate Tablets

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. [More]
People diagnosed with cancer are more likely to declare bankruptcy

People diagnosed with cancer are more likely to declare bankruptcy

People diagnosed with cancer are more than two-and-a-half times more likely to declare bankruptcy than those without cancer, according to a new study from Fred Hutchinson Cancer Research Center. Researchers also found that younger cancer patients had two- to five-fold higher bankruptcy rates compared to older patients, and that overall bankruptcy filings increased as time passed following diagnosis. [More]

Comprehensive survey can help health workers identify high-risk sexual behavior

A recent study by a team of researchers at the University of Nevada, Las Vegas found that risky sexual behavior can be predicted by cultural, socioeconomic and individual mores in conjunction with how one views themselves. [More]
National Institutes of Health names University of Rochester a Center for AIDS Research

National Institutes of Health names University of Rochester a Center for AIDS Research

The University of Rochester was named a Center for AIDS Research by the National Institutes of Health, a designation that infuses $7.5 million into HIV/AIDS work across the University and places it amongst the best in the nation for research to improve the prevention, detection and treatment of the disease. [More]

Scientists identify new class of immune cells that suppress genital herpes

Fred Hutchinson Cancer Research Center and University of Washington scientists have identified a class of immune cells that reside long-term in the genital skin and mucosa and are believed to be responsible for suppressing recurring outbreaks of genital herpes. [More]
AHF, KANCO organize NO RETREAT ON AIDS march to call for more global HIV/AIDS funding

AHF, KANCO organize NO RETREAT ON AIDS march to call for more global HIV/AIDS funding

Concerned that key partners in the fight against HIV & AIDS like the Global Fund to Fight AIDS, Tuberculosis and Malaria and the President's Emergency Plan for AIDS Relief are losing funding due to government cuts, AIDS Healthcare Foundation, in conjunction with Kenya AIDS NGOs Consortium, have organized a NO RETREAT ON AIDS march from Jevanjee Gardens to Uhuru Park on Friday May 10, 2013 to protest the loss of lifesaving and much-needed funding. [More]

Study provides additional data on why RV144 vaccine failed to protect more people

Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people. [More]
Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria. [More]
FDA approves sNDA for SUSTIVA for treatment of HIV-1 infected pediatric patients

FDA approves sNDA for SUSTIVA for treatment of HIV-1 infected pediatric patients

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a supplemental new drug application for SUSTIVA (efavirenz), including dosing recommendations for HIV-1 infected pediatric patients three months to three years old and weighing at least 3.5 kg. [More]
PEPFAR committed to programs aimed at children to reach AIDS-free generation

PEPFAR committed to programs aimed at children to reach AIDS-free generation

Citing data on how HIV/AIDS has affected children worldwide, whether directly or through the death of one or both parents, U.S. Global AIDS Coordinator Ambassador Eric Goosby, who also heads the State Department's Office of Global Health Diplomacy, writes in the agency's "DipNote" blog that children are vulnerable "to the social, emotional, economic, and environmental effects that HIV and AIDS has on families, communities, and countries." [More]
Men who take statins are less likely to die from prostate cancer, study finds

Men who take statins are less likely to die from prostate cancer, study finds

Men with prostate cancer who take cholesterol-lowering drugs called statins are significantly less likely to die from their cancer than men who don't take such medication, according to study led by researchers at Fred Hutchinson Cancer Research Center. [More]
Synthetic anti-inflammatory substances related to marijuana may help fight HIV infection

Synthetic anti-inflammatory substances related to marijuana may help fight HIV infection

HIV, the virus that causes AIDS, is notorious for hiding within certain types of cells, where it reproduces at a slowed rate and eventually gives rise to chronic inflammation, despite drug therapy. [More]

U.S. Global AIDS Coordinator Goosby to visit India this week

Ambassador Eric Goosby, head of the U.S. State Department's Office of Global Health Diplomacy and the U.S. Global AIDS Coordinator, "is travelling to India this week to recognize the successful health partnership between the two countries, an official statement said," the Press Trust of India/Business Standard reports. [More]

New screening guidelines: An important shift in HIV testing

Beth Meyerson, health policy expert at the Indiana University School of Public Health-Bloomington, said the new screening guidelines by the U.S. Preventive Services Task Force represent an important shift in HIV testing and will result in more HIV screenings because they will now be reimbursable. But the availability of the tests remains a big unknown. [More]
At library dedication, U.S. presidents praise Bush for work on HIV/AIDS, malaria while in office

At library dedication, U.S. presidents praise Bush for work on HIV/AIDS, malaria while in office

Last week, "[t]he George W. Bush Presidential Library dedication brought together five living presidents who have been at odds about much of the 43rd president's foreign policy legacy, particularly the Iraq war ... [b]ut they all agreed on, and offered effusive praise for, Bush's work on Africa," ABC News' "The Note" blog reports. [More]